Epidemiological and demographic characteristics of individuals with irritable bowel syndrome based on the Rome III vs. Rome IV criteria in the Northern part of Serbia

Download PDF Česká verzia

Authors: D. Slankamenac ¹; D. Dabic ²; A. Dabic ³; T. Slankamenac ⁴; A. Preveden ^4,5
Authors place of work: Department of Gastroenterology, General Hospital, Zrenjanin, Serbia ¹; Parexel, Serbia ²; Internal Department, General Hospital, Zrenjanin, Serbia ³; Pharmaceutical Faculty, University of Novi Sad, Novi Sad, Serbia ⁴; Institute of Cardiovascular Diseases Vojvodina, Sremska Kamenica, Serbia ⁵
Published in the journal: Gastroent Hepatol 2023; 77(1): 43-51
Category: Klinická a experimentální gastroenterologie: původní práce
doi: https://doi.org/10.48095/ccgh202338

Summary

Background: Rome IV diagnostic criteria offer a new definition of IBS as opposed to Rome III. Practically, there have been 3 main changes made from the Rome III criteria to IV, such as abdominal discomfort, the threshold for the frequency of abdominal pain, and the relation of abdominal pain in IBS to defecation. The aims of this study were epidemiology of the IBS population and comparison of the characteristics of the subjects who fulfill Rome III vs. those who fulfill both III and IV criteria with regard to the IBS diagnosis. Methods: A sample of adult healthy population from the Municipality of Zrenjanin area was investigated through a questionnaire. All the subjects were approached from 5^th March to 17^th June, 2020. The study was submitted to and approved by the local Ethics Committee at the city hospital. Results: Based on the conducted survey in the Zrenjanin area, the IBS prevalence was reported to be 26.97% based on Rome III criteria. A larger number of women aged 18–21 was reported to have IBS. The most prevalent subtype noted was IBS-C. A significant correlation was noted between smoking, alcohol, drug abuse, other comorbidities, patient characteristics and stress factors in the IBS identified subjects. Conclusions: To sum up, our study recommends young people to be screened for IBS. Any symptom of change in stool frequency or consistency should raise a suspicion of IBS after undergoing all the relevant investigations for ruling out organic diseases. This will aid their early diagnosis and will help to improve their quality of life.

Keywords:

irritable bowel syndrome – Rome III criteria – Rome IV criteria – epidemiology

Zdroje

1. Whitehead WE, Validation Working Team Committee in association with the Rome Questionnaire C. Development and validation of the Rome III diagnostic questionnaire. In: Drossman DA, ed. Rome III: the functional gastrointestinal disorders. 3rd ed. McLean VA: Degnon Associates Inc., 2006: 835–853.

2. Sainsbury A, Sanders DS, Ford AC. Prevalence of irritable bowel syndrome-type symptoms in patients with celiac disease: a meta-analysis. Clin Gastroenterol Hepatol 2013; 11 (4): 359.e1–365.e1. doi: 10.1016/j.cgh.2012.11.033.

3. Palsson OS, Whitehead WE, van Tilburg MA et al. Rome IV diagnostic questionnaires and tables for investigators and clinicians. Gastroenterology 2016; S0016-5085 (16) 00180-3. doi 10.1053/j.gastro.2016.02.014.

4. Francis CY, Morris J, Whorwell PJ. The irritable bo- wel severity scoring system: a simple method of monitoring irritable bowel syndrome and its pro- gress. Aliment Pharmacol Ther 1997; 11 (2): 395–402. doi: 10.1046/j.1365-2036.1997.142318000.x.

5. Wong R, Lee J, Fernandes M. Updates in gastrointestinal practice guidelines for the family physician. 2018 [online]. Dostupné z: https: //specialty.mims.com/topic/updates-in-gastrointestinal-practice-guidelines-for-the-family-physician.

6. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012; 10 (7): 712.e4–721.e4. doi: 10.1016/j.cgh.2012.02.029.

7. Hungin AP, Whorwell PJ, Tack J et al. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 2003; 17 (5): 643–650. doi: 10.1046/j.1365-2036.2003.01456.x.

8. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006; 130 (5): 1377–1390. doi: 10.1053/ j.gastro.2006.03.008.

9. Enck P, Aziz Q, Barbara G et al. Irritable bowel syndrome. Nat Rev Dis Primers 2016; 2: 16014. doi: 10.1038/nrdp.2016.14.

10. Kim JH, Lin E, Pimentel M. Biomarkers of Irritable Bowel Syndrome. J Neurogastroenterol Motil 2017; 23 (1): 20–26. doi: 10.5056/jnm16 135.

11. Oka P, Parr H, Barberio B et al. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2020; 5 (10): 908–917. doi: 10.1016/S2468-1253 (20) 30217-X.

12. Keszthelyi D, Dackus GH, Masclee GM et al. Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study. BMC Gastroenterol 2012; 12: 121. doi: 10.1186/1471-230X-12-121.

13. Adriani A, Ribaldone DG, Astegiano M et al. Irritable bowel syndrome: the clinical approach. Panminerva Med 2018; 60 (4): 213–222. doi: 10.23736/S0031-0808.18.03541-3.

14. Canavan C, West J, Card T. The epidemiology of irritable bowel syndrome. Clin Epidemiol 2014; 6: 71–80. doi: 10.2147/CLEP.S40 245.

15. Fairbrass KM, Selinger CP, Gracie DJ et al. Prevalence and impact of Rome IV versus Rome III irritable bowel syndrome in patients with inflammatory bowel disease. Neurogastroenterol Motil 2022; 34 (5): e14256. doi: 10.1111/ nmo.14 256.

16. Chatila R, Merhi M, Hariri E et al. Irritable bowel syndrome: prevalence, risk factors in an adult Lebanese population. BMC Gastroenterol 2017; 17 (1): 137. doi: 10.1186/s12876-017-0698-2.

17. Reding KW, Cain KC, Jarrett ME et al. Relationship between patterns of alcohol consumption and gastrointestinal symptoms among patients with irritable bowel syndrome. Am J Gastroenterol 2013; 108 (2): 270–276. doi: 10.1038/ajg.2012.414.

18. Alqahtani NH, Mahfouz ME. The Prevalence and Risk Factors of Irritable Bowel Syndrome in Saudi Arabia in 2019. Int J Prev Med 2022; 13: 13. doi: 10.4103/ijpvm.IJPVM_ 486_20.

19. Black CJ, Yiannakou Y, Houghton LA et al. Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria. Clin Gastroenterol Hepatol 2020; 18 (2): 392.e2–398.e2. doi: 10.1016/ j.cgh.2019.05.037.